Better Therapeutics, Inc. - BTTX

Sector: Healthcare · Industry: Services-Health Services
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2023 · Q3 2023
Value (USD)
Total reported value ($000)
$175K
QoQ value delta ($000)
-$126K (-41.86%)
Implied price effect (QoQ)
-48.64%
Shares
Total shares
931,010
QoQ shares delta
+108,639 (+13.21%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (BTTX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2023)

Top 25 only Full list
Early Q2 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
CITADEL ADVISORS LLC 42 219,165 0.0%
VANGUARD GROUP INC 38 198,154 0.0%
GEODE CAPITAL MANAGEMENT, LLC 32 168,821 0.0%
MILLENNIUM MANAGEMENT LLC 25 128,749 0.0%
STATE STREET CORP 11 58,600 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 7 38,057 0.0%
Corient Private Wealth LLC 5 29,180 0.0%
Tower Research Capital LLC (TRC) 4 22,443 0.0%
NORTHERN TRUST CORP 3 16,703 0.0%
AMERIPRISE FINANCIAL INC 2 15,000 0.0%
GROUP ONE TRADING, L.P. 2 10,351 0.0%
JANE STREET GROUP, LLC 2 10,336 0.0%
XTX Topco Ltd 2 14,472 0.0%
BANK OF AMERICA CORP /DE/ 0 216 0.0%
WELLS FARGO & COMPANY/MN 0 179 0.0%
ROYAL BANK OF CANADA 0 584 0.0%